Genmab A/SGMABNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank79
3Y CAGR-2.1%
5Y CAGR+30.6%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-2.1%/yr
vs +88.1%/yr prior
5Y CAGR
+30.6%/yr
Recent deceleration
Acceleration
-90.2pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
3.8x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $2.51B | -33.8% |
| 2024 | $3.79B | +15.0% |
| 2023 | $3.30B | +23.2% |
| 2022 | $2.68B | +108.6% |
| 2021 | $1.28B | +94.1% |
| 2020 | $661.00M | +93.3% |
| 2019 | $342.00M | +60.0% |
| 2018 | $213.69M | +45.4% |
| 2017 | $146.99M | +43.5% |
| 2016 | $102.41M | - |